SES. E. Evstifeeva

S. E. Evstifeeva

*This is an algorithmically generated author record based on publicly available information.

S. E. Evstifeeva has a total of 72 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Fatty liver index as a predictor of fatal and non-fatal cardiovascular events in Russians: analysis of an epidemiological cohort

    by S. E. Evstifeeva, S. A. Shalnova, V. A. Kutsenko, А. V. Kapustina, G. A. Muromtseva, Yu. A. Balanova, A. E. Imaeva, N. S. Karamnova, M. B. Kotova, S. A. Maksimov, et al.

    Aim. To study the associations of a high fatty liver index (FLI ≥60) with the risk of death and nonfatal cardiovascular events in a Russian epidemiological cohort. Material and methods. The analysis included data from ESSE-RF2 epidemiological study. FLI was calculated using the Bedogni G et al. equation (2006). A high FLI ≥60 was considered a predictor of liver steatosis. A total of 5381 individuals aged 25-64 years from 4 Russian regions (the Republic of Karelia, Krasnodar Krai, Omsk and Ryazan Oblasts) were included, of which 1672 had FLI ≥60. Fatal endpoints included all-cause (ACD) and cardiovascular death (CVD), while nonfatal endpoints included myocardial infarction (MI), cerebrovascular accident (CVA), heart failure progression (hospitalization), and revascularization. The composite endpoint (CE) included cardiovascular death or a non-fatal endpoint. Statistical analysis was performed using the R language and environment (version 4.2). The significance level for all tested hypotheses was pResults. Kaplan-Meier survival curve analysis showed that the group of patients with a FLI ≥60 had significantly worse survival outcomes compared to the group with an FLI Conclusion. In the group of individuals with a FLI ≥60, survival rates were significantly lower than in the group with a FLI <30 for all studied outcomes (ACD, CVD, and CE). In a univariate Cox regression model adjusted for region, a high FLI was associated with non-fatal CVA, ACD, CVD, and CE. However, in a multivariable model (adjusted for region, age, sex, lifestyle factors, and lipid metabolism disorders), a significant association of FLI ≥60 remained only with CE.

  • Open Access

    Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular risk factors (data from Russian epidemiological studies)

    by O. M. Drapkina, S. E. Evstifeeva, S. A. Shalnova, V. A. Kutsenko, Yu. A. Balanova, A. E. Imaeva, A. V. Kapustina, M. B. Kotova, S. A. Maksimov, G. A. Muromtseva, et al.

    Aim.  To study the prevalence of non-alcoholic fatty liver disease (NAFLD) and its association with cardiovascular risk factors (RFs). Material and methods.  The database from the ESSE-RF2 and ESSE-RF3 epidemiological studies was used, including data from surveys of population aged 35-64 years in 18 Russian regions (n=21204). To assess the prevalence of NAFLD, the fatty liver index (FLI) was used. Statistical analysis was performed using the statistical programming language and the R environment (version 3.6.1) with open-source code. The significance level for all tested hypotheses was p≤0,05. Results.  Standardized prevalence rates of FLI ≥60 in the ESSE-RF3 study are slightly higher than in the ESSE-RF2 study (39,2% vs 42,3%, respectively). Multivariate analysis adjusted for sex, age, region, settlement type, and education showed significant associations of FLI ≥60 with hypertension, type 2 diabetes, hyperuricemia, lipid metabolism disorders, elevated high-sensitivity C-reactive protein levels, and cerebrovascular accident in men and women. Conclusion.  Multivariate analysis confirmed the closest association of NAFLD with hypertension, type 2 diabetes mellitus, metabolic disorders, nonspecific inflammation, dyslipidemia, and cerebrovascular accident in men and women.